Baker Tilly Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,630
| Closed | -$222K | – | 521 |
|
|
2021
Q4 | $222K | Sell |
3,630
-3,050
| -46% | -$187K | 0.02% | 488 |
|
|
2021
Q3 | $499K | Sell |
6,680
-150
| -2% | -$11.2K | 0.07% | 314 |
|
|
2021
Q2 | $632K | Buy |
6,830
+300
| +5% | +$27.8K | 0.1% | 222 |
|
|
2021
Q1 | $579K | Buy |
6,530
+3,670
| +128% | +$325K | 0.12% | 210 |
|
|
2020
Q4 | $267K | Buy |
+2,860
| New | +$267K | 0.08% | 263 |
|